Vanguard Capital Management
DXCM icon

Vanguard Capital Management’s DexCom DXCM Stock Holding History

Vanguard Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7B Buy
25,209,752
+188,791
+0.8% +$12.6M 0.04% 367
2026
Q1 		$1.57B Buy
+25,020,961
New +$1.74B 0.04% 373

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Capital Management's DXCM Position: Q2 2026 in Review

Vanguard Capital Management increased its DexCom (DXCM) stake by 0.75% in Q2 2026, buying an estimated $12.6M and bringing the position to 25,209,752 shares worth $1.7B. The position accounts for 0.04% of the portfolio, ranked #367.

Vanguard Capital Management first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vanguard Capital Management held 25,209,752 shares of DexCom worth $1.7B as of Q2 2026.
  • Vanguard Capital Management bought 188,791 DexCom shares in Q2 2026, an estimated $12.6M.
  • DexCom made up 0.04% of Vanguard Capital Management's portfolio in Q2 2026, its #367 holding.
  • Vanguard Capital Management first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.